Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 07:32 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation
NCT05571111 · Ferring Pharmaceuticals · PHASE2 · withdrawn · last registry update 2023-01-09 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Based on company decision to close the project. No trial participants received any study drug.” | – | Registry record, Ferring Pharmaceuticals |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against LHCGR within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2023-12-14Results posted on the registry: Masonic Cancer Center, University of Minnesota, Pregnyl® (NCT02525029)
- 2023-11-07Results posted on the registry: Ferring Pharmaceuticals, MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL + MENOPUR powder and solvent for solution for injection, 75 IU (NCT04163458)
- 2022-11-30Also stopped (withdrawn): Assiut University, Letrozole + Menotropins (NCT04193930)
- 2022-11-01Phase 3 first posted: Beni-Suef University, 4 IU of recombinant GH (Somatotropin ) (NCT05602090)
- 2022-10-19Phase 3 first posted: Georgios Papadakis, Anastrozole + Semaglutide (NCT05586802)
- 2022-08-11Also stopped (terminated): IVI Madrid, Corifollitropin alfa (NCT02402192)
- 2022-05-31Phase 3 first posted: Alexandria University, 10000 IU hCG (Choriomon5000 IU; IBSA) + Triptorelin 0.2 mg (Decapeptyl 0.1 mg; Ferring) (NCT05397795)
- 2022-04-29Results posted on the registry: University of California, San Francisco, Low dose hCG plus FSH co-trigger + Standard dose of hCG (NCT02310919)
- 2022-02-17Results posted on the registry: El Shatby University Hospital for Obstetrics and Gynecology, Duphaston + Gonadotropin (NCT04537078)
- 2022-02-03Also stopped (withdrawn): Organon and Co, MK-8962 + recFSH (NCT01599494)
- 2022-01-28Also stopped (terminated): Reproductive Medicine Associates of New Jersey, a drug against LHCGR (NCT04852029)
- 2022-01-11Also stopped (withdrawn): Reproductive & Genetic Hospital of CITIC-Xiangya, intrauterine injection of HCG (NCT02870855)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision